Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Tenembaum

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Pharmaceutics|November 25, 2023
Population Pharmacodynamic Modelling of the CD19+ Suppression Effects of Rituximab in Paediatric Patients with Neurological and Autoimmune DiseasesNatalia Riva, Lucas Brstilo, Aymara Sancho-Araiz, et al.
Neurology|March 20, 2013
International Pediatric MS Study Group Clinical Trials Summit: meeting reportTanuja Chitnis, Marc Tardieu, Maria Pia Amato, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 11, 2013
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitionsLauren B Krupp, Marc Tardieu, Maria Pia Amato, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2020
Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerationsAngelo Ghezzi, Brenda Banwell, Amit Bar-Or, et al.
Neurology|August 31, 2016
International Pediatric MS Study Group Global Members Symposium reportEvangeline Wassmer, Tanuja Chitnis, Daniela Pohl, et al.
Neurology|February 20, 2015
MRI characteristics of neuromyelitis optica spectrum disorder: an international updateHo Jin Kim, Friedemann Paul, Marco A Lana-Peixoto, et al.
Frontiers in Pharmacology|February 14, 2022
Intensive Safety Monitoring of Rituximab (Biosimilar Novex<sup>®</sup> and the Innovator) in Pediatric Patients With Complex DiseasesNatalia Riva, Manuel Molina, Berta L Cornaló, et al.
Neurology|June 21, 2015
International consensus diagnostic criteria for neuromyelitis optica spectrum disordersDean M Wingerchuk, Brenda Banwell, Jeffrey L Bennett, et al.
JAMA Neurology|September 16, 2024
Differential Diagnosis of Suspected Multiple Sclerosis in Pediatric and Late-Onset Populations: A ReviewLe H Hua, Andrew J Solomon, Silvia Tenembaum, et al.
The Lancet. Neurology|January 27, 2023
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteriaBrenda Banwell, Jeffrey L Bennett, Romain Marignier, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Pharmaceutics|November 25, 2023
Population Pharmacodynamic Modelling of the CD19+ Suppression Effects of Rituximab in Paediatric Patients with Neurological and Autoimmune DiseasesNatalia Riva, Lucas Brstilo, Aymara Sancho-Araiz, et al.
Neurology|March 20, 2013
International Pediatric MS Study Group Clinical Trials Summit: meeting reportTanuja Chitnis, Marc Tardieu, Maria Pia Amato, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 11, 2013
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitionsLauren B Krupp, Marc Tardieu, Maria Pia Amato, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2020
Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerationsAngelo Ghezzi, Brenda Banwell, Amit Bar-Or, et al.
Neurology|August 31, 2016
International Pediatric MS Study Group Global Members Symposium reportEvangeline Wassmer, Tanuja Chitnis, Daniela Pohl, et al.
Neurology|February 20, 2015
MRI characteristics of neuromyelitis optica spectrum disorder: an international updateHo Jin Kim, Friedemann Paul, Marco A Lana-Peixoto, et al.
Frontiers in Pharmacology|February 14, 2022
Intensive Safety Monitoring of Rituximab (Biosimilar Novex<sup>®</sup> and the Innovator) in Pediatric Patients With Complex DiseasesNatalia Riva, Manuel Molina, Berta L Cornaló, et al.
Neurology|June 21, 2015
International consensus diagnostic criteria for neuromyelitis optica spectrum disordersDean M Wingerchuk, Brenda Banwell, Jeffrey L Bennett, et al.
JAMA Neurology|September 16, 2024
Differential Diagnosis of Suspected Multiple Sclerosis in Pediatric and Late-Onset Populations: A ReviewLe H Hua, Andrew J Solomon, Silvia Tenembaum, et al.
The Lancet. Neurology|January 27, 2023
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteriaBrenda Banwell, Jeffrey L Bennett, Romain Marignier, et al.
Pageof 4